In vitro viability and secretory capacity of human luteinized granulosa cells after gonadotropin-releasing hormone agonist trigger of oocyte maturation

Fertility and Sterility

Volumn 96, Issue 1, 2011, Pages 198-202

  Engmann, Lawrence ^a   Romak, Jonathan ^c   Nulsen, John ^a   Benadiva, Claudio ^a   Peluso, John ^b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

apoptosis; follicular fluid; GnRH agonist trigger; granulosa cells; granulosa luteal cells; VEGF

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN ANTAGONIST; LEUPRORELIN; PROGESTERONE; STEROID; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; CELL CULTURE; CELL SECRETION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; GRANULOSA CELL; HUMAN; HUMAN CELL; LUTEAL CELL; LUTEAL PHASE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY FOLLICLE FLUID; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CELL SURVIVAL; CELLS, CULTURED; FEMALE; GONADOTROPIN-RELEASING HORMONE; GRANULOSA CELLS; HUMANS; LEUPROLIDE; LUTEAL CELLS; OOCYTE RETRIEVAL; OOCYTES; PROSPECTIVE STUDIES;

EID: 79959888122     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.04.071     Document Type: Article

References (23)

1. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, and M. Gal Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum Reprod 21 2006 1260 1265
2. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
3. S. Kol, and J. Itskovitz-Eldor Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome - a 20-year experience Semin Reprod Med 28 2010 500 505
4. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, and K. Diedrich Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J Clin Endocrinol Metab 88 2003 4186 4192 (Pubitemid 37158033)
5. L. Engmann, L. Siano, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS Reprod Biomed Online 13 2006 639 644 (Pubitemid 44760886)
6. O. Nevo, T. Eldar-Geva, S. Kol, and J. Itskovitz-Eldor Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin Fertil Steril 79 2003 1123 1128 (Pubitemid 36547849)
7. M. Cerrillo, S. Rodríguez, M. Mayoral, A. Pacheco, J. Martínez-Salazar, and J.A. Garcia-Velasco Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus hCG: a rationale for OHSS reduction Fertil Steril 91 2009 1526 1528
8. P. Humaidan, H.E. Bredkjaer, L. Bungum, M.L. Grondahl, L. Westergaard, and C.Y. Anderson GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220 (Pubitemid 40796107)
9. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, and K. Diedrich A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892 (Pubitemid 41508652)
10. P. Humaidan Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study Reprod Biomed Online 18 2009 630 634
11. L. Engmann, R. Losel, M. Wehling, and J.J. Peluso Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism J Clin Endocrinol Metab 91 2006 4962 4968 (Pubitemid 44917335)
12. J.J. Peluso, and A. Pappalardo Progesterone regulates granulosa cell viability through a protein kinase G-dependent mechanism that may involve 14-3-3σ Biol Reprod 71 2004 1870 1878 (Pubitemid 39586931)
13. T. Hillensjo, and W.J. LeMaire Gonadotropin releasing hormone agonists stimulate meiotic maturation of follicle-enclosed rat oocytes in vitro Nature 287 1980 145 146 (Pubitemid 11227685)
14. C. Ekholm, T. Hillensjo, and O. Isaksson Gonadotropin releasing hormone agonists stimulate oocyte meiosis and ovulation in hypophysectomized rats Endocrinology 108 1981 2022 2024 (Pubitemid 12196330)
15. Y. Yoshimura, Y. Nakamura, T. Oda, H. Yamada, T. Nanno, and M. Ando Effects of gonadotropin-releasing hormone agonists on meiotic maturation of follicle-enclosed oocytes in rabbits Biol Reprod 43 1990 1012 1018
16. S.R. Soares, R. Gómez, C. Simón, J.A. García- Velasco, and A. Pellicer Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome Hum Reprod Update 14 2008 321 333 (Pubitemid 351858972)
17. M. Cerrillo, A. Pacheco, S. Rodríguez, R. Gómez, F. Delgado, and A. Pellicer Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome Fertil Steril 2011 10.1016/j.fertnstert.2010.12.054
18. P. Humaidan, H.E. Bredkjær, L.G. Westergaard, and C. Yding Andersen 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil Steril 93 2010 847 854
19. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, and J. Itskovitz-Eldor Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715 (Pubitemid 34158241)
20. R. Agrawal, S.L. Tan, S. Wild, P. Sladkevicius, L. Engmann, and N. Payne Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome Fertil Steril 71 1999 287 293 (Pubitemid 29069906)
21. B. Acevedo, J.L. Gomez-Palomares, E. Ricciarelli, and E.R. Hernández Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates Fertil Steril 86 2006 1682 1687 (Pubitemid 44781379)
22. A.J. DiLuigi, L. Engmann, D.W. Schmidt, D.B. Maier, J.C. Nulsen, and C.A. Benadiva Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting Fertil Steril 94 2000 1111 1114
23. E. Hormbrey, P. Gillespie, K. Turner, C. Han, A. Roberts, and D. McGrouther A critical review of vascular endothelial growth factor (VEGF) analysis in peripheral blood: is the current literature meaningful? Clin Exp Metastasis 19 2002 651 663 (Pubitemid 36092260)